Canton Strategic Holdings has executed the first trades of tokenized common stock under the SEC's Innovation Exemption, marking a significant milestone.

Canton Strategic Holdings sets a new precedent by announcing plans to tokenize its equity, ensuring compliance with SEC regulations and offering 24/7 trading options.

Canton Strategic Holdings, Inc. has released its financial results for Q2 2026, highlighting initial revenue from its new services, marking a pivotal step in its growth strategy.

Canton Strategic Holdings, Inc. announces the election of three experienced directors to its board, enhancing governance as the company implements its Canton Network strategy.

Canton Strategic Holdings has sold its biotech arm, Gravitas Life Sciences, marking a significant shift towards its Canton Network strategy for market digitization.

Canton Strategic Holdings has announced a new locking service aimed at enhancing network infrastructure, driving liquidity for Super Validators, and optimizing capital management.

Canton Strategic Holdings, Inc. is anticipated to be included in the Russell 3000 and Russell 2000 indices, marking a significant milestone for the company.

Canton Strategic Holdings, a pioneer in leveraging blockchain for finance, introduces a share repurchase program worth $50 million, enhancing shareholder confidence and aligning with its strategic goals.